2.Metabolic alkalosis induced by plasmapheresis in a patient with systemic lupus erythematosus.
Moon Young CHOI ; Joung Deuk LEE ; Seung Hun LEE ; In Seok PARK ; Je Young WOO ; Euy Jin CHOI ; Yoon Sik CHANG ; Byung Kee BANG
Journal of Korean Medical Science 1993;8(3):207-209
We report a patient with systemic lupus erythematosus (SLE), who had developed metabolic alkalosis during plasmapheresis. The metabolic alkalosis could be promptly corrected by reducing the amount of citrate load. The development of metabolic alkalosis can be explained by the citrate load during plasmapheresis. Careful monitoring of acid base status is mandatory in patients with limited renal function and the reduction of citrate load may be advisable in plasmapheresis.
Adolescent
;
Alkalosis/*etiology
;
Citrates
;
Citric Acid
;
Female
;
Humans
;
Lupus Erythematosus, Systemic/*metabolism/therapy
;
Plasmapheresis/*adverse effects/methods
3.Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis.
Se Hee MIN ; Anita PHUNG ; Tae Jung OH ; Kyou Sup HAN ; Man Jin KIM ; Jee Min KIM ; Ji Hyun LEE ; Young Joo PARK
Journal of Korean Medical Science 2015;30(10):1531-1534
Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 35-yr-old man with thyrotoxicosis, ultimately attributed to Graves' disease in whom antithyroid drug used initially was soon discontinued, due to abnormal liver function, and replaced by Lugol's solution. Three weeks later, an escape phenomenon (to Lugol's solution) was apparent, so we performed TPE to control the thyrotoxicosis. Two courses of TPE by a centrifugal type machine resulted in diminished levels of thyroid hormone levels, which then rebounded after another two courses of membrane filtration type TPE. However, the patient could be treated with radioactive iodine therapy without any complications at present.
Adult
;
Antithyroid Agents/adverse effects/therapeutic use
;
Cetirizine/adverse effects/therapeutic use
;
Graves Disease/*radiotherapy
;
Hepatitis B, Chronic/complications
;
Humans
;
Iodides/therapeutic use
;
Iodine Radioisotopes/*therapeutic use
;
Male
;
Methimazole/adverse effects/therapeutic use
;
Plasmapheresis/*methods
;
Thyroid Gland/*pathology
;
Thyrotoxicosis/*therapy